Report Library
All ReportsDatamonitor Healthcare Oncology: NHL: Diffuse Large B-Cell Lymphoma (DLBCL) Disease Coverage
October 09, 2018
Diffuse large B-cell lymphoma (DLBCL) is a form of hematological malignancy that affects B lymphocytes. This cancer is the most common
type of non-Hodgkin’s lymphoma (NHL), accounting for about one-third of all newly diagnosed cases. The disease occurs predominantly in
older people, with a median age of diagnosis around 65 years, and has a slightly higher prevalence in men than in women. DLBCL is
categorized as an aggressive form of NHL; after initial onset the cancer advances quickly and can be fatal if left untreated. However, prompt
and suitable treatment can lead to cure in more than 50% of cases.
This Datamonitor Healthcare Disease Coverage report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.
This Datamonitor Healthcare Disease Coverage report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.
Indications Covered: | Diffuse Large B-Cell Lymphoma (DLBCL) - NHL |